Search

Your search keyword '"Migraine -- Drug therapy -- Research"' showing total 180 results
Start Over Descriptor "Migraine -- Drug therapy -- Research"
180 results on '"Migraine -- Drug therapy -- Research"'

151. Studies from University College London (UCL) Reveal New Findings on Traumatic Brain Injury (Vestibular Rehabilitation Therapy for the Treatment of Vestibular Migraine, and the Impact of Traumatic Brain Injury On Outcome: a Retrospective Study)

Subjects
Brain research -- Research, Brain -- Research -- Injuries, Medical research, Medicine, Experimental, Migraine -- Drug therapy -- Research, Health
Abstract

2022 MAR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Central Nervous System Diseases and Conditions - Traumatic Brain [...]

Published
2022

153. Researchers from University of L'Aquila Describe Findings in Migraine (Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index)

Subjects
Migraine -- Drug therapy -- Research, Immunotherapy -- Reports -- Research, Health
Abstract

2022 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on migraine. According to news reporting out of L'Aquila, Italy, by [...]

Published
2022

154. Findings in Migraine Reported from Chinese People's Liberation Army (PLA) Medical School (Advances in acute and preventive treatment of migraine)

Subjects
China. People's Liberation Army -- Reports, Nervous system diseases -- Drug therapy -- Research, Migraine -- Drug therapy -- Research, Health
Abstract

2022 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- New study results on migraine have been published. According to news [...]

Published
2022

155. Recent Findings from School of Medicine Has Provided New Information about Headache [Reliability and Validity of Turkish Version of Headache Impact Test (Hit-6) In Patients With Migraine]

Subjects
Medical research -- Reports, Medicine, Experimental -- Reports, Nervous system diseases -- Drug therapy -- Research, Migraine -- Drug therapy -- Research, Health
Abstract

2022 MAR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Nervous System Diseases and Conditions - Headache is now [...]

Published
2022

156. Report Summarizes Neck Pain Study Findings from Sechenov First Moscow State Medical University (Treatment of chronic migraine and neck pain with cognitive-behavioral therapy. Case report)

Subjects
Cognitive therapy -- Research -- Analysis, Migraine -- Drug therapy -- Research, Behavior therapy -- Research -- Analysis, Behavioral health care -- Research -- Analysis, Analgesics -- Research, Anxiety -- Drug therapy -- Research, Neck pain -- Drug therapy -- Research, Health
Abstract

2022 FEB 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in neck pain. According to news reporting from Sechenov [...]

Published
2022

157. First Affiliated Hospital of Soochow University Researchers Provide New Study Findings on Migraine (The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials)

Subjects
Medical research -- Reports, Medicine, Experimental -- Reports, Migraine -- Drug therapy -- Research, Clinical trials -- Research -- Reports, Health
Abstract

2022 FEB 18 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New study results on migraine have been published. According to news reporting originating [...]

Published
2022

158. Reports Outline Migraine Study Findings from College of Medicine (Efficacy profile of noninvasive vagus nerve stimulation on cortical spreading depression susceptibility and the tissue response in a rat model)

Subjects
School construction -- Models -- Research -- Reports, Migraine -- Drug therapy -- Research, Health, Health care industry
Abstract

2022 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Investigators publish new report on migraine. According to news reporting out [...]

Published
2022

159. University of Balikesir Details Findings in Migraine (The Effectiveness of Sphenopalatine Ganglion Blockade In Chronic Migraine Resistant To Medical Treatment)

Subjects
Medical research, Medicine, Experimental, Migraine -- Drug therapy -- Research, Ganglion -- Research -- Drug therapy, Health
Abstract

2022 FEB 7 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Researchers detail new data in Primary Headache Diseases and Conditions - [...]

Published
2022

160. Isfahan University of Medical Sciences Researchers Discuss Research in Science (The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines)

Subjects
Migraine -- Drug therapy -- Research, Nitric oxide -- Research, Lactates -- Research, Health, Science and technology
Abstract

2022 JAN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Science Letter -- Researchers detail new data in science. According to news reporting originating from Isfahan University of [...]

Published
2022

161. Researchers from Charite University Hospital and School of Medicine Describe Research in Headache [Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with ...]

Subjects
Migraine -- Drug therapy -- Research, Monoclonal antibodies -- Research, Health
Abstract

2022 JAN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on headache. According to news originating from Charite University [...]

Published
2022

162. Orally inhaled dihydroergotamine: a novel ergot delivery method for the treatment of migraine

Author

Phung, Olivia J.

Subjects
Dihydroergotamine -- Dosage and administration -- Chemical properties, Pharmacokinetics -- Research, Migraine -- Drug therapy -- Research, Pharmaceuticals and cosmetics industries
Abstract

Abstract Orally inhaled dihydroergotamine (DHE) is a newly developed formulation of DHE for the treatment of acute migraine attack and is undergoing FDA review. This new agent provides an alternative [...]

Published
2012

163. New Findings from Scripps Clinic Update Understanding of Headache (IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trial)

Subjects
Clinical trials, Powders (Particulate matter), Medical research, Ketorolac -- Research, Nervous system diseases -- Drug therapy -- Research, Drug approval, Oral drugs -- Research, Migraine -- Drug therapy -- Research, Anti-inflammatory agents, Finance, Headache, Diseases, Nonsteroidal anti-inflammatory agents, Setting (Literature), Generic drugs, Editors, Health
Abstract

2020 APR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Nervous System Diseases and Conditions - Headache have been [...]

Published
2020

164. Petadolex for the treatment of headache: a profile of a special butterbur extract; pharmacology, safety, and clinical aspects

Author

Danesch, Ulrich

Subjects
Petasite -- Health aspects -- Research, Migraine -- Drug therapy -- Research, Medicine, Botanic -- Research -- Health aspects, Medicine, Herbal -- Research -- Health aspects, Health, Drug therapy, Research, Health aspects
Abstract

Introduction Petasites hybridus is a perennial shrub native to Europe, northern Africa, and southwestern Asia. It is also known under its common name butterbur. The use of preparations from Petasites [...]

Published
2003

165. Pharmacoeconomic analysis of oral triptans

Author

Ho, Mei-Jen, Joish, Vijay N., LaFleur, Joanne, Christensen, Russell L., and Brixner, Diana I.

Subjects
Triptans -- Dosage and administration -- Prices and rates -- Evaluation, Migraine -- Drug therapy -- Research, Drug therapy -- Evaluation -- Prices and rates -- Dosage and administration, Pharmaceuticals and cosmetics industries, Company pricing policy, Drug therapy, Evaluation, Research, Prices and rates, Dosage and administration
Abstract

A study was conducted to determine the most cost-efficacious oral tiptan for the treatment of migraines from a managed care perspective. INTRODUCTION Migraines affect 28 million Americans (1) and contribute [...]

Published
2004

166. Butterbur

Author

Sego, Sherril

Subjects
Petasite -- Research -- Health aspects -- Complications and side effects, Migraine -- Drug therapy -- Research, Medicine, Botanic -- Research -- Health aspects, Allergic reaction -- Research -- Drug therapy, Medicine, Herbal -- Research -- Health aspects, Allergy -- Research -- Drug therapy, Asthma -- Research -- Drug therapy, Health
Abstract

A perennial plant found in Europe, southwestern Asia, and north Africa, butterbur is also referred to as exwort, butter dock, and bog rhubarb. (1) For decades the commercial use of [...]

Published
2010

167. Without optimal treatment, episodic migraine may progress to chronic migraine

Subjects
Migraine -- Drug therapy -- Research, Pharmaceuticals and cosmetics industries
Abstract

from Staff Reports Individuals with episodic migraine (EM; ICHD-2 defined migraine with headache on average It has been previously established that 2% to 3% of individuals in the population with [...]

Published
2013

168. Valproate teratogenicity highlighted

Subjects
Bipolar disorder -- Drug therapy -- Research, Migraine -- Drug therapy -- Research, Valproic acid -- Health aspects -- Research -- Complications and side effects -- Licensing, certification and accreditation, Divalproex -- Health aspects -- Research -- Complications and side effects -- Licensing, certification and accreditation, Health, Health care industry
Abstract

The high risk of neural tube defects and other major malformations in babies exposed during the first trimester to valproate sodium and the related products, valproic acid and divalproex sodium, [...]

Published
2010

169. OTC import reduces children's migraine attacks

Subjects
Migraine -- Drug therapy -- Research, Pediatric pharmacology -- Research, Health
Abstract

A preparation of butterbur root extract has performed so safely and effectively in trials involving both children and adults as to be recommended by Richard M. Lipton, MD, a board [...]

Published
2008

170. Newer drugs no better for migraine prophylaxis

Author

Wachter, Kerri

Subjects
Migraine -- Drug therapy -- Research, Propranolol hydrochloride -- Dosage and administration -- Research, Topiramate -- Dosage and administration -- Research, Health, Health care industry
Abstract

Washington -- Newer drugs aren't any better for migraine prophylaxis than are older treatments and may be worse choices for many patients when cost is a factor. 'There's no proof [...]

Published
2008

171. Glaxo's headaches

Subjects
Glaxo Pharmaceuticals Inc. -- Product development, Sumatriptan -- Product development -- Research, Serotonin -- Receptors, Migraine -- Drug therapy -- Research, Pharmaceutical industry -- Product development, Business, Economics, Business, international, Drug therapy, Research, Product development
Abstract

A CURE for migraine would be a medical breakthrough and a commercial blockbuster, which is just what Glaxo, a large British drug company, needs. Patents on Zantac, the ulcer cure [...]

Published
1990

172. Two drugs work better for migraine than monotherapy

Author

Alper, Brian S.

Subjects
Sumatriptan -- Dosage and administration -- Research, Migraine -- Drug therapy -- Research, Naproxen -- Dosage and administration -- Research, Health
Abstract

TWO DRUGS WORK BETTER FOR MIGRAINE THAN MONOTHERAPY Level 2: Mid-level evidence Both sumatriptan (Imitrex) and naproxen sodium (Aleve, others) are used to treat a migraine attack. A new but [...]

Published
2007

173. Migraine treatment hampered by poor interviews

Author

Dixon, Bruce K.

Subjects
Migraine -- Drug therapy -- Research, Physician and patient -- Health aspects -- Research, Health, Health care industry
Abstract

SCOTTSDALE, ARIZ. -- Open-ended questions during the patient interviews elicit the best information for guiding the management of patients with migraine headache, Dr. Richard B. Lipton said at a symposium [...]

Published
2007

174. Topiramate prevents migraines better than placebo

Subjects
Migraine -- Drug therapy -- Research, Topiramate -- Dosage and administration -- Research, Health care industry, Drug therapy, Research, Dosage and administration
Abstract

Clinical question Is topiramate effective in preventing migraine headaches? Bottom line Topiramate (Topamax), 100 mg or 200 mg daily, is more effective than placebo in preventing migraine headaches in patients [...]

Published
2004

176. Studies from Albert Einstein College of Medicine Have Provided New Information about Headache and Migraine

Subjects
Headache -- Drug therapy -- Research, Migraine -- Drug therapy -- Research, Universities and colleges -- New York, Health, World Health Organization, Yeshiva University. Albert Einstein College of Medicine
Abstract

By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Investigators publish new report on Headache and Migraine. According to news reporting from Bronx, New York, [...]

Published
2012

177. Research Results from Washington University School of Medicine Update Understanding of Headache and Migraine

Subjects
Headache -- Drug therapy -- Research, Migraine -- Drug therapy -- Research, Calcium channels -- Research, Universities and colleges -- Missouri, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

Research findings, 'Effects of familial hemiplegic migraine type 1 mutation T666M on voltage-gated calcium channel activities in trigeminal ganglion neurons,' are discussed in a new report. According to the authors [...]

Published
2012

178. Rizatriptan edged rivals for Migraine relief. (Merck-Sponsored Study)

Subjects
Merck & Company Inc. -- Research, Migraine -- Drug therapy -- Research, Health, Health care industry
Abstract

DENVER -- Migraine patients consistently reported that rizatriptan outperformed their usual headache medications in a large study designed to mimic real-world clinical practice, Dr. Dara G. Jamieson said at the [...]

Published
2002

179. JournalWatch: Combination for migraine

Subjects
Sumatriptan -- Dosage and administration -- Research, Migraine -- Drug therapy -- Research, Drug therapy, Combination -- Research, Naproxen -- Dosage and administration -- Research, Health, Health care industry
Abstract

Combination treatment with sumatriptan and naproxen is more effective than monotherapy for acute migraine, a US study concludes. The researchers conducted two replicate randomised trials involving 1,461 and 1,495 patients [...]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results